ASX
Neuren Pharmaceuticals Limited
NEU:ASX•Healthcare
Sensitive ASX Announcement
First subject commences Neuren's Rett syndrome Phase 2 trial
Published: 07/04/16, 10:48am (AEST)•2 pages